DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Clinical trial NCT06988475 · RECRUITING

Trial details

NCT number: NCT06988475
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Solid Tumour Haematological Malignancy Malignant Neoplasm Neoplasms by Histologic Type Neoplasms by Site Cancer Malignancy Glioma Neuroblastoma Gastric Cancer Soft Tissue Sarcoma

Start date: 2024-11-19
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.